Skip to content

Harm Reduction Within Comprehensive Treatment of Opioid Use Disorder: The Example of Take-Home Naloxone | Prof. Sir John Strang

2024 APA Scientific Conference

Please click "Next" if you did not attend this session
100%
The session met the stated learning objectives:(Required.)
Strongly disagree
Disagree
Somewhat disagree
Neither agree or disagree
Somewhat agree
Agree
Strongly agree
Comprehensive care and treatment of patients who may, alongside other disorders, suffer from Substance Use Disorders.
Comprehensive treatment requires us to meet the patient where they are, and walk with them through their personalised journey of recovery.
The high risk of relapse and danger of overdose death requires us to teach patients and their families about emergency interim management of overdose emergency, and pre-provision of the opioid antagonist naloxone.
Please rate the following on a scale of 1 to 5
(1 - strongly disagree and 5 - strongly agree):(Required.)
Strongly disagree
Disagree
Somewhat disagree
Neither agree or disagree
Somewhat agree
Agree
Strongly agree
The session was educationally relevant.
The presenter was educationally effective.
The session provided interactive opportunities.
The session provided opportunities to identify and/or reflect on what was learned and its potential impact on my practice
Please rate the following on a scale of 1 to 5
(1 - strongly disagree and 5 - strongly agree):(Required.)
Strongly disagree
Disagree
Somewhat disagree
Neither agree or disagree
Somewhat agree
Agree
Strongly agree
The session and presenter did NOT have commercial or other inappropriate bias.
Please provide any other comments you would like to share: